Stockreport

EMA recommends compassionate use of Gilead's remdesivir for COVID-19 [Yahoo! Finance News]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF April 3 ) - The European Medicines Agency EMA) on Friday recommended Gilead Sciences Inc's investigational antiviral drug remdesivir should be used for treating COVID-19 [Read more]